Pharmacy- Page 11

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA in China and Asia Pacific Region

The FINANCIAL -- Pfizer Inc. and Basilea Pharmaceutica Ltd., an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, on November 1 announced they have entered into an agreement whereby Pfizer will be granted the exclusive development

by The FINANCIAL

December 1, 2017

1 min read

Pharmacy

Bayer combines pharmaceutical research and development unit

The FINANCIAL -- Following the formation of a dedicated strategic business unit oncology earlier this year within its pharmaceuticals division, Bayer announced on November 30 to further strengthen its strategic pharmaceutical research and development activities and bring them together under one leadership.

by The FINANCIAL

November 30, 2017

1 min read

Pharmacy

Merck Announces Increased Quarterly Dividend

The FINANCIAL -- Merck on November 28 announced that the Board of Directors has increased the company’s quarterly dividend to $0.48 per outstanding share of the company’s common stock, up $0.01 from $0.47 per outstanding share paid last quarter.

by The FINANCIAL

November 29, 2017

1 min read

Pharmacy

Teva Announces New Organization Structure and Leadership Changes

The FINANCIAL -- Teva Pharmaceutical Industries Ltd. announced on November 27 a new organization and leadership structure aimed to achieve better commercial focus and drive value creation.

by The FINANCIAL

November 28, 2017

5 mins read

Pharmacy

Bayer is expanding its collaboration with Bitkom

The FINANCIAL -- Bayer is deepening its ties with Bitkom, Germany's digital association, and is bolstering its support for digital innovation in the areas of health care and agriculture.

by The FINANCIAL

November 27, 2017

1 min read

Pharmacy

Roche to acquire Viewics, Inc.

The FINANCIAL -- Roche on November 17 announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. Under the agreement, Roche is acquiring all shares of the company.

by The FINANCIAL

November 17, 2017

1 min read

Pharmacy

Pfizer Receives FDA Approval for SUTENT

The FINANCIAL -- Pfizer Inc. on November 16 announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT (sunitinib malate) to include the adjuvant treatment of adult patients at high risk of recurrent renal

by The FINANCIAL

November 17, 2017

7 mins read

Pharmacy

Faslodex receives US FDA approval for the treatment of advanced breast cancer in combination with abemaciclib

The FINANCIAL -- AstraZeneca on November 15 announced that the US Food and Drug Administration (FDA) has approved a new indication for Faslodex (fulvestrant), expanding the indication to include use with abemaciclib, a CDK4/6 inhibitor, for the treatment of hormone receptor-positive (HR+),

by The FINANCIAL

November 15, 2017

1 min read

Pharmacy

Takeda Receives Positive CHMP Opinion for ADCETRIS

The FINANCIAL -- Takeda Pharmaceutical Company Limited on November 14 announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and

by The FINANCIAL

November 15, 2017

2 mins read